[Skip to Content]
[Skip to Content Landing]
Article
February 23, 1918

FEDERAL TRADE COMMISSION REQUESTS USE OF OFFICIAL NAMES

Author Affiliations

Washington, D. C. Secretary, Federal Trade Commission.

JAMA. 1918;70(8):558. doi:10.1001/jama.1918.02600080060020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.

Abstract

To the Editor:  —Nothing is further from the intention of this commission than to attempt to influence the editorial or advertising policy of any publication, but it is believed that an effort should be made to secure the general use of the new official names in connection with the drugs, licenses to manufacture which have been granted by this commission. To this end we suggest that The Journal of the American Medical Association (if such course meets its approval) use the official names "Arsphenamine," "Procaine," "Barbital," etc., in connection with all advertisements of the products and all articles in which they are referred to.

First Page Preview View Large
First page PDF preview
First page PDF preview
×